Women’s deep belly fat more strongly linked to diabetes and cardiovascular diseases
A comprehensive study from IGP, with over 325,000 participants, shows that deep belly fat is a major contributing risk factor for developing diabetes and cardiovascular disease. The study also shows that deep belly fat is a larger risk factor in women compared to men. Moreover, the scientists investigated how our genes affect the accumulation of fat and present a new, simpler method to estimate the amount of deep belly fat.
Visceral fat – fat stored around the organs in the belly and around the intestines – is known to be associated with a higher risk of developing diabetes and cardiovascular disease. In the new study, published in Nature Medicine, the scientists took it one step further and showed, using genetic data, that there is an actual causal relationship between visceral fat and increased risk of diabetes, heart attack, hypertension and hyperlipidemia.
The scientists developed a method to more easily estimate visceral fat content. The method is not only useful for research purposes, but may also be useful in health care.
“To measure the amount of visceral fat, advanced and costly diagnostic imaging techniques are required. We have developed a simple method which instead estimates an individual’s amount of deep belly fat from other parameters, more easily measured than the visceral fat itself, and the method can therefore be used in most clinics,” says Torgny Karlsson, statistician at IGP and one of the leading researchers of the study.
The method also enabled the researchers to study the effects of visceral fat on a much larger scale than before.
“We were surprised that visceral fat was more strongly linked to risk of disease in women compared to men. Adding an extra kilogram of visceral fat can increases the risk of type 2 diabetes more than seven times in women, while the same amount of fat accumulation only increases the risk a little more than two times in men,” says Åsa Johansson, last author of the published paper.
The scientists also found that the risk of disease increases most rapidly in people with small or moderate amounts of deep belly fat, but that it does not increase nearly as much if a person with large amounts of fat in the abdomen puts on additional fat.
“Nonlinear effects like this are very interesting to study and may help us to understand the biology behind the link between visceral fat and disease,” says Torgny Karlsson.
The scientists also examined millions of positions in the genome to identify genes that affect the amount of visceral fat, and found more than two hundred different genes. Among these, there was a large proportion of genes that are linked to our behaviour, which suggests that the main contributor to abdominal obesity is, after all, that we eat too much and exercise too little. However, there are individual differences in how the fat is distributed in the body, and a person who appears not to be overweight may still have accumulated a harmful amount of visceral fat.
“The findings of this study may enable us to simplify measurements of visceral fat, and thus more easily identify people at high risk of developing diabetes and cardiovascular disease,” says Torgny Karlsson.
Disrupted immune cell navigation in lymph nodes of breast cancer patients
Different types of breast cancer tumours differ in how they affect the function of the lymph nodes. In patients with invasive breast cancer, the vessels and supporting tissue of the lymph nodes are altered, which cannot be seen in patients with a non-invasive cancer called (ductal cancer in situ). This is shown in a new study from Maria Ulvmar’s group at IGP, published online in the scientific journal Cancers.
Oral contraceptive pills protect against ovarian and endometrial cancer
A comprehensive study from Uppsala University, involving more than 250,000 women, shows that oral contraceptive use protects against ovarian and endometrial cancer. The protective effect remains for several decades after discontinuing the use. The study is published in the journal Cancer Research.
Vener bakom blodkärlsmissbildningar i hjärnan
In the condition known as cavernoma, lesions arise in a cluster of blood vessels in the brain, spinal cord or retina. Researchers in Elisabetta Dejana's group at IGP can now show, at molecular level, that these changes originate in vein cells. This new knowledge of the condition creates potential for developing better therapies for patients. The study has been published in the journal eLife.
World’s largest ever DNA sequencing of Vikings
Genetic examinations of more than 400 Viking age skeletons reveal that the Vikings that raided Europe came from relatively isolated groups in Scandinavia and many of them had a genetic influx from Asia or Southern Europe. This is presented in a study in the journal Nature, in which Marie Allen and Magdalena Bus from IGP have participated.
Internet-based support can reduce depressions symptoms in cancer patients
The internet can be used to provide education and support for self-management interventions to alleviate depression symptoms in individuals with cancer. This is shown in a study from Birgitta Johansson’s group at IGP.
Leakage from blood and lymphatic vessels is differently regulated
Researchers from IGP show in a new study that cell signalling regulating vessel leakage differs between blood and lymphatic vessels. The findings suggest a possibility to modulate this signalling in order to selectively control lymphatic vessel function and to treat diseases characterised by lymphatic vessel leakage.
New early biomarker for several cancer diseases
In a study including more than 400 hospital patients with 18 different cancer diagnoses, researchers have been able to show that EVP, extracellular vesicles and particles, could be used as biomarkers for several cancer diseases. The study has been led by researchers from among others IGP.
New findings on enzymes with important role in SARS-CoV-2 infection
Researchers at IGP have described the presence, throughout the human body, of the enzyme ACE2. This is thought to be the key protein used by the SARS-CoV-2 virus for host cell entry and development of the disease COVID-19. In contrast to previous studies, the study shows that no or very little ACE2 protein is present in the normal respiratory system. The results are presented in Molecular Systems Biology.
Unexpected associations found between drug response and cell changes in brain cancer
Therapies for treating glioblastoma brain cancer can be delivered with greater precision and existing drugs can be used in new ways. These are the conclusions from a study from IGP investigating a large number of cell samples from patients with brain tumours. The researchers have characterised how changes in glioblastoma cells influence the effect of different drugs. Their findings are published in the journal Cell Reports.
New method to identify genes that can drive development of brain tumors
Researchers at Uppsala University have developed a method for identifying functional mutations and how these affect genes with significance for the development of glioblastoma – a malignant brain tumor with very poor prognosis. The study is published in Genome Biology.
New effective way to inhibit lymphatic malformations
Lymphatic malformation is a debilitating and often incurable disease. Taija Mäkinen’s research group has in an international collaboration studied cellular mechanisms leading to abnormal vessel growth and identified a combination therapy that may allow effective treatment of these malformations.
Lymphatic vessels in mice and humans: alike yet different
In an international collaboration, researchers from IGP have mapped the lymph node lymphatic vessels in mice and humans down to the level of individual cells. The results may eventually help scientists to discover new methods for strengthening the immune system against viruses and cancer. Their work has been published in the journal Frontiers of Cardiovascular Research.
Scientists identify cause of leakiness in eye diseases
Targeting a molecule that contributes to leaky eye vessels, while sparing nerve and blood-vessel cells, could be a safer treatment strategy for age and diabetes-related vision loss. Scientists at IGP have identified a key step in the process that leads to leaky vessels and harmful swelling in eye diseases, according to a new study published today in the journal eLife.
Changes in cellular degradation hubs can lead to cancer
Cancer cells grow and divide in an uncontrolled manner. A new study from IGP now shows how alterations in a cell’s degradation hubs, called lysosomes, can cause abnormal cell growth. The results are published today in the scientific journal Nature Communications.
Careless cancer cells may be susceptible to future drugs
Could the ability of cancer cells to quickly alter their genome be used as a weapon against malignant tumours? Researchers at IGP have succeeded in developing a substance that has demonstrated promising results in experiments on both animal models and human cancer cells. The study is published in the journal Nature Communications.
Smart algorithm finds possible future treatment for childhood cancer
Using a computer algorithm, scientists at IGP have identified a promising new treatment for neuroblastoma. This form of cancer in children, which occurs in specialised nerve cells in the sympathetic nervous system, may be life-threatening. In the long term the discovery, described in the latest issue of the scientific journal Nature Communications, may result in a new form of treatment for children in whom the disease is severe or at an advanced stage.